DE2549999C2 - - Google Patents

Info

Publication number
DE2549999C2
DE2549999C2 DE2549999A DE2549999A DE2549999C2 DE 2549999 C2 DE2549999 C2 DE 2549999C2 DE 2549999 A DE2549999 A DE 2549999A DE 2549999 A DE2549999 A DE 2549999A DE 2549999 C2 DE2549999 C2 DE 2549999C2
Authority
DE
Germany
Prior art keywords
general formula
derivative
piperidine
given above
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2549999A
Other languages
German (de)
English (en)
Other versions
DE2549999A1 (de
Inventor
Walter-Gunar Dr.Rer.Nat. 6100 Darmstadt De Friebe
Max Dr.Rer.Nat. Thiel
Kurt Dr.-Ing. 6800 Mannheim De Stach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Priority to DE19752549999 priority Critical patent/DE2549999A1/de
Priority to ZA766381A priority patent/ZA766381B/xx
Priority to CA264,608A priority patent/CA1077942A/en
Priority to IE2394/76A priority patent/IE43866B1/en
Priority to US05/737,518 priority patent/US4243807A/en
Priority to HU76BO00001639A priority patent/HU171237B/hu
Priority to DK494876A priority patent/DK494876A/da
Priority to SU762415648A priority patent/SU633473A3/ru
Priority to CH1385576A priority patent/CH624102A5/de
Priority to FI763148A priority patent/FI763148A7/fi
Priority to SE7612234A priority patent/SE7612234L/xx
Priority to DD195610A priority patent/DD126942A5/xx
Priority to BE172068A priority patent/BE847973A/xx
Priority to GB45916/76A priority patent/GB1502050A/en
Priority to JP51133139A priority patent/JPS6055509B2/ja
Priority to NL7612286A priority patent/NL7612286A/xx
Priority to IT29083/76A priority patent/IT1063618B/it
Priority to AT823776A priority patent/AT352726B/de
Priority to FR7633389A priority patent/FR2330678A1/fr
Priority to LU76141A priority patent/LU76141A1/xx
Publication of DE2549999A1 publication Critical patent/DE2549999A1/de
Priority to SU772534003A priority patent/SU662009A3/ru
Priority to SU772534004A priority patent/SU867298A3/ru
Priority to AT712578A priority patent/AT360020B/de
Priority to AT712478A priority patent/AT360019B/de
Priority to CH742380A priority patent/CH625788A5/de
Priority to CH742480A priority patent/CH627166A5/de
Application granted granted Critical
Publication of DE2549999C2 publication Critical patent/DE2549999C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
DE19752549999 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung Granted DE2549999A1 (de)

Priority Applications (26)

Application Number Priority Date Filing Date Title
DE19752549999 DE2549999A1 (de) 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung
ZA766381A ZA766381B (en) 1975-11-07 1976-10-25 New piperidine derivatives
CA264,608A CA1077942A (en) 1975-11-07 1976-10-28 4-phenoxymethylpiperidine compounds
IE2394/76A IE43866B1 (en) 1975-11-07 1976-10-29 Piperidine derivatives
US05/737,518 US4243807A (en) 1975-11-07 1976-11-01 4-Phenoxymethyl-piperidines
HU76BO00001639A HU171237B (hu) 1975-11-07 1976-11-01 Sposob poluchenija proizvodnykh 4-/fenoksi-metil/-piperidina
DK494876A DK494876A (da) 1975-11-07 1976-11-02 Fremgangsmade til fremstilling af piperidinderivater
SU762415648A SU633473A3 (ru) 1975-11-07 1976-11-02 Способ получени производных пиперидина или их солей
FI763148A FI763148A7 (OSRAM) 1975-11-07 1976-11-03
SE7612234A SE7612234L (sv) 1975-11-07 1976-11-03 Nya piperidinderivat.
CH1385576A CH624102A5 (OSRAM) 1975-11-07 1976-11-03
GB45916/76A GB1502050A (en) 1975-11-07 1976-11-04 Piperidine derivatives
DD195610A DD126942A5 (OSRAM) 1975-11-07 1976-11-04
BE172068A BE847973A (fr) 1975-11-07 1976-11-04 Nouveaux derives de la piperidine et procedes pour leur preparation,
NL7612286A NL7612286A (nl) 1975-11-07 1976-11-05 Piperidinederivaten en werkwijze voor hun be- reiding.
IT29083/76A IT1063618B (it) 1975-11-07 1976-11-05 Derivati piperidinici e processo per la loro preparazione
AT823776A AT352726B (de) 1975-11-07 1976-11-05 Verfahren zur herstellung von neuen piperidin- derivaten und deren salzen
FR7633389A FR2330678A1 (fr) 1975-11-07 1976-11-05 Derives de piperidine et leur procede de preparation
LU76141A LU76141A1 (OSRAM) 1975-11-07 1976-11-05
JP51133139A JPS6055509B2 (ja) 1975-11-07 1976-11-05 ピペリジン誘導体およびその製造法
SU772534003A SU662009A3 (ru) 1975-11-07 1977-10-21 Способ получени производных пиперидина или их солей
SU772534004A SU867298A3 (ru) 1975-11-07 1977-10-21 Способ получени производных пиперидина или их солей
AT712578A AT360020B (de) 1975-11-07 1978-10-03 Verfahren zur herstellung von neuen piperidin- derivaten und deren salzen
AT712478A AT360019B (de) 1975-11-07 1978-10-03 Verfahren zur herstellung von neuen piperidin- derivaten und deren salzen
CH742380A CH625788A5 (OSRAM) 1975-11-07 1980-10-03
CH742480A CH627166A5 (OSRAM) 1975-11-07 1980-10-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19752549999 DE2549999A1 (de) 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
DE2549999A1 DE2549999A1 (de) 1977-05-12
DE2549999C2 true DE2549999C2 (OSRAM) 1989-01-26

Family

ID=5961166

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752549999 Granted DE2549999A1 (de) 1975-11-07 1975-11-07 Piperidin-derivate und verfahren zu ihrer herstellung

Country Status (20)

Country Link
US (1) US4243807A (OSRAM)
JP (1) JPS6055509B2 (OSRAM)
AT (1) AT352726B (OSRAM)
BE (1) BE847973A (OSRAM)
CA (1) CA1077942A (OSRAM)
CH (3) CH624102A5 (OSRAM)
DD (1) DD126942A5 (OSRAM)
DE (1) DE2549999A1 (OSRAM)
DK (1) DK494876A (OSRAM)
FI (1) FI763148A7 (OSRAM)
FR (1) FR2330678A1 (OSRAM)
GB (1) GB1502050A (OSRAM)
HU (1) HU171237B (OSRAM)
IE (1) IE43866B1 (OSRAM)
IT (1) IT1063618B (OSRAM)
LU (1) LU76141A1 (OSRAM)
NL (1) NL7612286A (OSRAM)
SE (1) SE7612234L (OSRAM)
SU (3) SU633473A3 (OSRAM)
ZA (1) ZA766381B (OSRAM)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA848275B (en) * 1983-12-28 1985-08-28 Degussa New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring
US4556664A (en) * 1984-03-13 1985-12-03 Gunnar A. K. Aberg Method and composition for the treatment of cardiac arrhythmias
IE66332B1 (en) * 1986-11-03 1995-12-27 Novo Nordisk As Piperidine compounds and their preparation and use
US5231184A (en) * 1987-11-23 1993-07-27 Janssen Pharmaceutica N.V. Pridazinamine derivatives
US4822778A (en) * 1988-01-19 1989-04-18 Gunnar Aberg Membrane stabilizing phenoxy-piperidine compounds and pharmaceutical compositions employing such compounds
US5109002A (en) * 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
FR2667317B1 (fr) * 1990-10-02 1992-12-04 Synthelabo Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
HUT68769A (en) * 1991-05-07 1995-07-28 Merck & Co Inc FIBRINOGéN RECEPTOR ANTAGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS EFFECTIVE SUBSTANCE
US5272158A (en) * 1991-10-29 1993-12-21 Merck & Co., Inc. Fibrinogen receptor antagonists
US5389631A (en) * 1991-10-29 1995-02-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5416099A (en) * 1991-10-29 1995-05-16 Merck & Co., Inc. Fibrinogen receptor antagonists
US5358956A (en) * 1992-10-14 1994-10-25 Merck & Co., Inc. Fibrinogen receptor antagonists
JPH08502484A (ja) * 1992-10-14 1996-03-19 メルク エンド カンパニー インコーポレーテッド フィブリノゲンリセプタ拮抗剤
WO1994012181A1 (en) * 1992-12-01 1994-06-09 Merck & Co., Inc. Fibrinogen receptor antagonists
US5441952A (en) * 1993-04-05 1995-08-15 Merck & Co., Inc. Fibrinogen receptor antagonists
US5334596A (en) * 1993-05-11 1994-08-02 Merck & Co., Inc. Fibrinogen receptor antagonists
US5397791A (en) * 1993-08-09 1995-03-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5821241A (en) * 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5719144A (en) * 1995-02-22 1998-02-17 Merck & Co., Inc. Fibrinogen receptor antagonists
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
WO1997011939A1 (en) * 1995-09-28 1997-04-03 Kaken Pharmaceutical Co., Ltd. Process for the preparation of 4-methylenepiperidines
US5789421A (en) * 1995-10-26 1998-08-04 Merck & Co., Inc. Fibrinogen receptor antagonist
US5780480A (en) * 1996-02-28 1998-07-14 Merck & Co., Inc. Fibrinogen receptor antagonists
US5889023A (en) * 1996-05-10 1999-03-30 Merck & Co., Inc. Fibrinogen receptor antagonist
US5981584A (en) * 1997-02-06 1999-11-09 Merck & Co., Inc. Fibrinogen receptor antagonist prodrugs
JP5405571B2 (ja) 2008-07-24 2014-02-05 セラヴァンス， インコーポレーテッド ３−（フェノキシフェニルメチル）ピロリジン化合物
WO2010056939A1 (en) 2008-11-14 2010-05-20 Theravance, Inc. Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
JP2012524098A (ja) * 2009-04-15 2012-10-11 セラヴァンス， インコーポレーテッド ３−（フェノキシピロリジン−３−イル−メチル）ヘテロアリール、３−（フェニルピロリジン−３−イルメトキシ）ヘテロアリールおよび３−（ヘテロアリールピロリジン−３−イルメトキシ）ヘテロアリール化合物
NZ597433A (en) 2009-07-13 2013-12-20 Theravance Inc 3-phenoxymethylpyrrolidine compounds
EP2456436B1 (en) 2009-07-21 2014-06-25 Theravance, Inc. 3-phenoxymethylpyrrolidine compounds
JP5705239B2 (ja) * 2010-01-11 2015-04-22 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー セロトニンおよびノルエピネフリン再取込みインヒビターとしての１−（２−フェノキシメチルフェニル）ピペラジン化合物
EP2550252B1 (en) * 2010-03-22 2015-05-06 Theravance Biopharma R&D IP, LLC 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds
JP5873877B2 (ja) 2010-10-11 2016-03-01 セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー セロトニン再取込みインヒビター
US8501964B2 (en) 2010-12-03 2013-08-06 Theravance, Inc. Serotonin reuptake inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268951A (en) * 1969-06-12 1972-03-29 Pfizer Ltd Phenoxy-amines
DE2245061A1 (de) * 1972-09-14 1974-03-28 Boehringer Mannheim Gmbh Derivate des adenins
DE2401254A1 (de) * 1974-01-11 1975-11-27 Boehringer Mannheim Gmbh Neue derivate von n hoch 6-substituierten adeninen
DE2550000A1 (de) * 1975-11-07 1977-05-12 Boehringer Mannheim Gmbh Neue purin-derivate und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
SU633473A3 (ru) 1978-11-15
AT352726B (de) 1979-10-10
US4243807A (en) 1981-01-06
NL7612286A (nl) 1977-05-10
CH624102A5 (OSRAM) 1981-07-15
SE7612234L (sv) 1977-05-07
IE43866B1 (en) 1981-06-17
JPS5259163A (en) 1977-05-16
DE2549999A1 (de) 1977-05-12
ATA823776A (de) 1979-03-15
HU171237B (hu) 1977-12-28
IE43866L (en) 1977-05-07
DD126942A5 (OSRAM) 1977-08-24
LU76141A1 (OSRAM) 1977-05-18
DK494876A (da) 1977-05-08
CH625788A5 (OSRAM) 1981-10-15
ZA766381B (en) 1977-10-26
FI763148A7 (OSRAM) 1977-05-08
CA1077942A (en) 1980-05-20
CH627166A5 (OSRAM) 1981-12-31
IT1063618B (it) 1985-02-11
SU867298A3 (ru) 1981-09-23
FR2330678A1 (fr) 1977-06-03
BE847973A (fr) 1977-05-04
GB1502050A (en) 1978-02-22
FR2330678B1 (OSRAM) 1980-11-07
SU662009A3 (ru) 1979-05-05
JPS6055509B2 (ja) 1985-12-05

Similar Documents

Publication Publication Date Title
DE2549999C2 (OSRAM)
DE69723846T2 (de) Verfahren zur Herstellung von Sildenafil
EP0007019A1 (de) Neue 5-Phenylpyrazol-Derivate und ihre Salze; Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE1595920A1 (de) 4-(omega-Piperazinoalkyl)-pyrazole,ihre Salze und Verfahren zu ihrer Herstellung
CH597199A5 (en) 3-Phenyl pyridaz-6-ones prodn.
DE69013726T2 (de) Verbessertes Verfahren für die Herstellung von o-Carboxypyridyl- und o-Carboxychinolylimidazolinonen.
DE955595C (de) Verfahren zur Herstellung von spasmolytisch wirksamen basischen AEthern endocyclisch substituierter Carbinole und ihren Salzen
US2928843A (en) Basic esters and salts thereof
DE2406972C3 (de) Verfahren zur Herstellung von 5-Sulfamoylanthranilsäuren
AT360019B (de) Verfahren zur herstellung von neuen piperidin- derivaten und deren salzen
DE2533919A1 (de) Verfahren zur herstellung von cyclohexandionen-(1.3)
DE3816634A1 (de) Cyclobuten-3,4-dion-zwischenverbindungen, verfahren zu ihrer herstellung und ihre verwendung
DE2604248C2 (de) Verfahren zur Herstellung von Thienopyridinderivaten
DE2636722A1 (de) 3-hydroxy-pyrrolinon-2-derivate
DE1620658C (de) l-Phenyl-4-aminopyrazolderivate und Verfahren zu ihrer Herstellung
DE2156049A1 (de) Tetrahy dro-isochinolinderivate
EP0180707A1 (de) Verfahren zur Herstellung von Muzolimin
DE1593349C (OSRAM)
DE1570034A1 (de) Verfahren zur Herstellung von Nikotinsaeureamiden
DE2338409A1 (de) Neues verfahren zur herstellung von 2-acylamino-benzylaminen
AT204554B (de) Verfahren zur Herstellung von N-Alkyl-α-piperidincarbonsäureaniliden
AT260928B (de) Verfahren zur Herstellung von neuen Halogenalkenyl- bzw. Alkenylpiperidinen sowie von deren Säureadditionssalzen
AT359210B (de) Verfahren zur herstellung von desoxyvincamin- amiden
AT344687B (de) Verfahren zur herstellung von neuen aldehydolactonen
AT254189B (de) Verfahren zur Herstellung von neuen substituierten 3-(3-Hydroxyphenyl)-1-phenacylpiperidinen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee